Historical record - last NADAC effective date: 1/1/2018
Product Information
SAFYRAL TABLET is a brand product labeled by Bayer HealthCare Pharmaceuticals Inc., priced at $6.8201 per EA under NDC 50419040303. Its NADAC has been published 269 times since Nov 28, 2013.
FDA first approved this application on Dec 16, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
SAFYRAL TABLET
Drospirenone/ethinyl estradiol/levomefolate calcium and levomefolate calciumManufacturer
Bayer HealthCare Pharmaceuticals Inc.NDC
50419040303
Classification
Brand
Dosage Form
KIT
Effective Date
1/1/2018
Approval Type
New Drug (NDA)
FDA Application
NDA022574FDA Approved
12/16/2010
TE Code
AB
On Market Since
2/13/2012
Price Statistics
The NADAC for SAFYRAL TABLET has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 111.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8201 per EA |
|---|---|
| All-time high | $6.8201 (Jan 16, 2019) |
| All-time low | $3.2243 (Nov 28, 2013) |
| Median price | $5.1630 |
| Average price | $5.1632 |
| Largest weekly change | +9.9% (Feb 18, 2015) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+111.5%
Last surveyed Jan 16, 2019 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 79% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SAFYRAL TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SAFYRAL TABLET, manufactured by Bayer HealthCare Pharmaceuticals Inc., is $6.8201 per EA (NDC 50419040303), effective Jan 16, 2019.
How has the price of SAFYRAL TABLET changed over time?
Over the history we have for it, the NADAC for SAFYRAL TABLET has risen 111.5%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SAFYRAL TABLET?
Since Nov 28, 2013, the NADAC for SAFYRAL TABLET has ranged from a low of $3.2243 (Nov 28, 2013) to a high of $6.8201 (Jan 16, 2019), with a median of $5.1630 per EA.
Are there cheaper alternatives to SAFYRAL TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, DROSP-EE-LEVOMEF 3-0.02-0.451, is $1.4023 per EA — about 79% below SAFYRAL TABLET.
Who manufactures SAFYRAL TABLET?
SAFYRAL TABLET (NDC 50419040303) is labeled by Bayer HealthCare Pharmaceuticals Inc., and CMS classifies it as a brand product.